Pretreatment of docetaxel enhances TRAIL
β
Jinsang Yoo; Sung-Soo Park; Yong J. Lee
π
Article
π
2008
π
John Wiley and Sons
π
English
β 367 KB
π 1 views
## Abstract Tumor necrosis factorβrelated apoptosisβinducing ligand (TRAIL) is a promising cancer therapeutic agent because of its tumor selectivity. TRAIL is known to induce apoptosis in cancer cells but spare most normal cells. In this study, we examined whether treatment of docetaxel (DTX) can e